Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$68.40 USD
-0.24 (-0.35%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $68.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (87 out of 249)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.20 | 1.35 | 9.99 |
Current Quarter Estimate | 1.58 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 1.34 | 0.12 | 54.84 |
Next Quarter Estimate | 1.75 | 7.81 | 63.00 |
Next Year Estimate | 7.24 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -44.05 | 15.50 | 15.67 |
Next Year | 92.55 | 9.60 | 9.31 |
Last 5 Years | -0.70 | 3.70 | 8.10 |
Next 5 Years | 6.30 | 20.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 17.03 | -2.18 |
Price/Book (MRQ) | 4.90 | 1.93 |
Price/Cash Flow (MRFY) | 7.67 | 15.24 |
Dividend Yield | 4.49% | 0.00% |
Net Profit Margin (TTM) | 1.76% | -180.54% |
Return on Equity (TTM) | 24.34% | -35.38% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.